Launch of HIV vaccine clinical trials ...Zimbabwe takes part
|
The trial, known as IAVI C114, is enrolling approximately
120 healthy adults aged 18 to 50, including 48 people on antiretroviral
therapy and are ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...